6-96610726-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001322466.2(FHL5):c.659A>G(p.Asn220Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001322466.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL5 | ENST00000450218.6 | c.659A>G | p.Asn220Ser | missense_variant | Exon 5 of 6 | 5 | NM_001322466.2 | ENSP00000396390.2 | ||
FHL5 | ENST00000326771.2 | c.659A>G | p.Asn220Ser | missense_variant | Exon 6 of 7 | 1 | ENSP00000326022.2 | |||
FHL5 | ENST00000541107.5 | c.659A>G | p.Asn220Ser | missense_variant | Exon 5 of 6 | 1 | ENSP00000442357.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.659A>G (p.N220S) alteration is located in exon 6 (coding exon 4) of the FHL5 gene. This alteration results from a A to G substitution at nucleotide position 659, causing the asparagine (N) at amino acid position 220 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.